Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |